Track FATE and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
FATE - Fate Therapeutics Inc (FATE) has a earnings per share of -$0.26, up 18.8% over the past year.
Latest EPS (Actual)
-$0.26
Beat Rate
50.0%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.28 | -$0.26 | Beat | +7.14% |
| Feb 2026 | -$0.27 | -$0.27 | Meet | +0.00% |
| Nov 2025 | -$0.28 | -$0.27 | Meet | +3.57% |
| Aug 2025 | -$0.34 | -$0.29 | Beat | +14.71% |
| May 2025 | -$0.38 | -$0.32 | Beat | +15.79% |
| Feb 2025 | -$0.42 | -$0.44 | Meet | -3.82% |
| Nov 2024 | -$0.41 | -$0.40 | Meet | +2.44% |
| Aug 2024 | -$0.45 | -$0.33 | Beat | +26.67% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.